Amello Jason (CIK 0001451805)

Latest company ownership

Shares held
202,009
Last filed at
Nov 30, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q4 2025Q4
Shares held
45,000
Last filed at
Mar 2, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q1 2025Q4
Shares held
22,377
Last filed at
May 14, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 28, 2023 Nov 30, 2023 Candel Therapeutics, Inc. CFO Sell 46.3 -20,153 -9.07% ✗ $18.1K
Dec 8, 2022 Dec 12, 2022 Candel Therapeutics, Inc. CFO Buy 91.3 +5,568 100.00% ✗ $10K
Feb 28, 2020 Mar 2, 2020 Akebia Therapeutics, Inc. CFO Sell 95.0 +23,024 18.93% ✗ $60.7K
Apr 11, 2019 Apr 12, 2019 Akebia Therapeutics, Inc. CFO Sell 22.5 -13,148 -9.98% ✗ $101.2K
Dec 12, 2018 Dec 13, 2018 Akebia Therapeutics, Inc. CFO Sell 22.5 -22,235 -25.06% ✗ $198.8K
Nov 26, 2014 Dec 1, 2014 Akebia Therapeutics, Inc. CFO Buy 91.3 +1,000 25.00% ✗ $13.2K
Mar 25, 2014 Mar 27, 2014 Akebia Therapeutics, Inc. CFO Buy 95.0 +4,000 100.00% ✗ $68K
May 8, 2013 May 14, 2013 Alaunos Therapeutics, Inc. CFO Sell 47.5 -2,623 -10.49% ✗ $4.3K